156 related articles for article (PubMed ID: 17977516)
1. Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells.
Rytting E; Audus KL
Biochem Pharmacol; 2008 Feb; 75(3):745-51. PubMed ID: 17977516
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta.
Karahoda R; Ceckova M; Staud F
Toxicol Appl Pharmacol; 2019 Apr; 368():18-25. PubMed ID: 30735677
[TBL] [Abstract][Full Text] [Related]
3. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells.
Rytting E; Audus KL
J Pharmacol Exp Ther; 2005 Jan; 312(1):192-8. PubMed ID: 15316089
[TBL] [Abstract][Full Text] [Related]
4. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
6. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier.
Tachikawa M; Takeda Y; Tomi M; Hosoya K
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):430-6. PubMed ID: 19684012
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
8. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells.
Rytting E; Audus KL
J Pharm Pharmacol; 2007 Aug; 59(8):1095-102. PubMed ID: 17725851
[TBL] [Abstract][Full Text] [Related]
9. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
10. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
11. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
12. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5).
Kou L; Sun R; Ganapathy V; Yao Q; Chen R
Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
17. Carnitine transport: pathophysiology and metabolism of known molecular defects.
Tein I
J Inherit Metab Dis; 2003; 26(2-3):147-69. PubMed ID: 12889657
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
[TBL] [Abstract][Full Text] [Related]
19. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.
Rytting E; Bryan J; Southard M; Audus KL
Biochem Pharmacol; 2007 Mar; 73(6):891-900. PubMed ID: 17174940
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
Wang Y; Ye J; Ganapathy V; Longo N
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
